Falko Ernst Wolter

This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbott Gmbh & Co Kg. Active years: 2012-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Falko Ernst Wolter. Retrieved from https://idiyas.com/inventor/falko-ernst-wolter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 27(Granted Patents)

Location History:

Mannheim, DE (2016)
Ludwigshafen, DE (2012 - 2018)

Company Filing History:

2 out of 167

Abbvie Deutschland Gmbh and Co Kg

Years Active: 2012-2018

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10100048 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2018-10-16),

2. 9266855 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2016-02-23),

3. 8318793 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2012-11-27),

Title: Falko Ernst Wolter: Innovator in Heterocyclic Compounds

Introduction

Falko Ernst Wolter is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of heterocyclic compounds. With a total of 3 patents, his work focuses on innovative solutions for medical treatments.

Latest Patents

Wolter's latest patents include groundbreaking research on heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors. The present invention relates to novel heterocyclic compounds that are useful for inhibiting glycogen synthase kinase 3 (GSK-3). This includes methods of making the compounds, compositions containing the compounds, and methods of treatment using these compounds.

Career Highlights

Throughout his career, Falko Ernst Wolter has worked with prominent companies such as AbbVie Deutschland GmbH & Co. KG and Abbott GmbH & Co. KG. His experience in these organizations has allowed him to develop and refine his expertise in the pharmaceutical industry.

Collaborations

Wolter has collaborated with several professionals in his field, including Sean Colm Turner and Margaretha Henrica Maria Bakker. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Falko Ernst Wolter is a distinguished inventor whose work in heterocyclic compounds has the potential to impact medical treatments significantly. His innovative approach and collaborations highlight his commitment to advancing pharmaceutical science.

Profile summary based on public USPTO records.